Baker / Tisch Capital (gp), Llc - Net Worth and Insider Trading
Baker / Tisch Capital (gp), Llc Net Worth
The estimated net worth of Baker / Tisch Capital (gp), Llc is at least $103 Million dollars as of 2024-09-20. Baker / Tisch Capital (gp), Llc is the Director, 10% Owner of Seagen Inc and owns about 400,898 shares of Seagen Inc (SGEN) stock worth over $92 Million. Baker / Tisch Capital (gp), Llc is the Director, 10% Owner of Incyte Corp and owns about 159,739 shares of Incyte Corp (INCY) stock worth over $11 Million. Baker / Tisch Capital (gp), Llc is also the 10% Owner of BioCryst Pharmaceuticals Inc and owns about 25,042 shares of BioCryst Pharmaceuticals Inc (BCRX) stock worth over $204,343. Details can be seen in Baker / Tisch Capital (gp), Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Baker / Tisch Capital (gp), Llc has not made any transactions after 2010-09-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Baker / Tisch Capital (gp), Llc
Baker / Tisch Capital (gp), Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Baker / Tisch Capital (gp), Llc owns 4 companies in total, including Seagen Inc (SGEN) , Heron Therapeutics Inc (HRTX) , and Incyte Corp (INCY) among others .
Click here to see the complete history of Baker / Tisch Capital (gp), Llc’s form 4 insider trades.
Insider Ownership Summary of Baker / Tisch Capital (gp), Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SGEN | Seagen Inc | 2009-05-20 | director & 10 percent owner |
| HRTX | Heron Therapeutics Inc | 2009-10-19 | 10 percent owner |
| INCY | Incyte Corp | 2010-09-23 | director |
 | | 2007-08-06 | 10 percent owner |
Baker / Tisch Capital (gp), Llc Latest Holdings Summary
Baker / Tisch Capital (gp), Llc currently owns a total of 3 stocks. Among these stocks, Baker / Tisch Capital (gp), Llc owns 400,898 shares of Seagen Inc (SGEN) as of May 20, 2009, with a value of $92 Million and a weighting of 89.39%. Baker / Tisch Capital (gp), Llc owns 159,739 shares of Incyte Corp (INCY) as of September 23, 2010, with a value of $11 Million and a weighting of 10.41%. Baker / Tisch Capital (gp), Llc also owns 25,042 shares of BioCryst Pharmaceuticals Inc (BCRX) as of August 6, 2007, with a value of $204,343 and a weighting of 0.2%.
Latest Holdings of Baker / Tisch Capital (gp), Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SGEN | Seagen Inc | 2009-05-20 | 400,898 | 228.74 | 91,701,409 |
| INCY | Incyte Corp | 2010-09-23 | 159,739 | 66.85 | 10,678,552 |
| BCRX | BioCryst Pharmaceuticals Inc | 2007-08-06 | 25,042 | 8.16 | 204,343 |
Holding Weightings of Baker / Tisch Capital (gp), Llc
Baker / Tisch Capital (gp), Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Baker / Tisch Capital (gp), Llc has made a total of 0 transactions in Seagen Inc (SGEN) over the past 5 years. The most-recent trade in Seagen Inc is the acquisition of 35,253 shares on May 20, 2009, which cost Baker / Tisch Capital (gp), Llc around $342,659.
According to the SEC Form 4 filings, Baker / Tisch Capital (gp), Llc has made a total of 0 transactions in Incyte Corp (INCY) over the past 5 years. The most-recent trade in Incyte Corp is the sale of 21,623 shares on September 23, 2010, which brought Baker / Tisch Capital (gp), Llc around $321,750.
According to the SEC Form 4 filings, Baker / Tisch Capital (gp), Llc has made a total of 0 transactions in BioCryst Pharmaceuticals Inc (BCRX) over the past 5 years. The most-recent trade in BioCryst Pharmaceuticals Inc is the sale of 0 shares on August 6, 2007, which brought Baker / Tisch Capital (gp), Llc around $0.
Insider Trading History of Baker / Tisch Capital (gp), Llc
- 1
Baker / Tisch Capital (gp), Llc Trading Performance
GuruFocus tracks the stock performance after each of Baker / Tisch Capital (gp), Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Baker / Tisch Capital (gp), Llc is 9.73%. GuruFocus also compares Baker / Tisch Capital (gp), Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Baker / Tisch Capital (gp), Llc within 3 months outperforms 18 times out of 25 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Baker / Tisch Capital (gp), Llc's insider trading performs compared to the benchmark.
Performance of Baker / Tisch Capital (gp), Llc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.27 | | | | | |
| Relative Return to S&P 500(%) | 3.9 | | | | | |
Baker / Tisch Capital (gp), Llc Ownership Network
Baker / Tisch Capital (gp), Llc Owned Company Details
What does Seagen Inc do?
Who are the key executives at Seagen Inc?
Baker / Tisch Capital (gp), Llc is the director & 10 percent owner of Seagen Inc. Other key executives at Seagen Inc include director & Chief Executive Officer David R Epstein , See Remarks Vaughn B Himes , and EVP & Commercial Charles R Romp .
Seagen Inc (SGEN) Insider Trades Summary
Over the past 18 months, Baker / Tisch Capital (gp), Llc made no insider transaction in Seagen Inc (SGEN). Other recent insider transactions involving Seagen Inc (SGEN) include a net sale of 36,274 shares made by Vaughn B Himes , a net sale of 2,228 shares made by Charles R Romp , and a net sale of 58,274 shares made by Todd E Simpson .
In summary, during the past 3 months, insiders sold 0 shares of Seagen Inc (SGEN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 195,202 shares of Seagen Inc (SGEN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 195,202 shares.
Seagen Inc (SGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Seagen Inc Insider Transactions
Baker / Tisch Capital (gp), Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Baker / Tisch Capital (gp), Llc. You might contact Baker / Tisch Capital (gp), Llc via mailing address: 667 Madison Ave, 21st Floor, New York Ny 10065.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
